EXPATICA BIOPHARMACEUTICA Pvt. Ltd. and ABTEC Ltd. Sign MoU to Advance R and D YELM Pro Launched by Honble Governor of West Bengal
EXPATICA BIOPHARMACEUTICA Pvt. Ltd. and ABTEC Ltd. Sign MoU to Advance R and D YELM Pro Launched by Honble Governor of West Bengal
EXPATICA BIOPHARMACEUTICA signed a Memorandum of Understanding (MoU) with the Agro Biotech Research Center Ltd. (ABTEC), presided over by the Honorable H. E. Dr. C. V. Anand Bose, Governor of West Bengal; Chairman of the ABTEC Ltd., Mr. K. M. Jacob; Dr. Sachindra Nath Mandal (Executive Director, EXPATICA BIOPHARMACEUTICA); and Dr. Mithilesh Kumar Jaiswal (Additional Director, R&D).
EXPATICA BIOPHARMACEUTICA PVT. LTD., a company based in Mumbai, the “City of Dreams,” guided by the philosophy “Expert guide to biopharmaceuticals,” is an ISO 9001 and GMP certified member of the Association of Industry Veterinarians and Researchers. EXPATICA BIOPHARMACEUTICA is a new-generation, research-driven, innovative Indian biopharmaceuticals company offering new levels of excellence in veterinary pharmaceutical formulations for better animal health & nutrition through the use of a broad range of “eco-safe innovative biotic components.”
Agro Biotech Research Center Ltd., a company based in Kottayam, “City of Letters,” stands at the forefront of bioscience innovation, dedicated to advancing human, animal, and plant health through cutting-edge scientific research. ABTEC Ltd. is committed to developing natural and organic products. Guided by a passion for innovation and a dedication to research excellence, ABTEC has evolved into a leading force in the bioscience industry.
This MoU has been signed to collaborate on Research and Development (R&D) initiatives. Under the MoU, the two organizations aim to build a knowledge platform to support. This strategic partnership aims to leverage the strengths of both companies to develop innovative probiotic and phytobiotic solutions for the agro-veterinary segment. The collaboration will focus on sharing of good global practices in animal nutrition and technology.
YLEM Pro® is a unique combination of 4-in-1 clinically studied postbiotics, paraprobiotics, probiotics, and prebiotics that work in synergy to enhance trained immunity and support a balanced gut microbiome. The term “YLEM” is related to the concept of “the Cosmic egg,” also referred to as “Bramhand (Universe),” as it contains multiple components for various functions. This product is a new multi-pronged approach to replace antibiotics. The YLEM Pro® is the outcome of the R&D initiatives of EXPATICA in collaboration with Agro Bio-Tech Research Centre Ltd. (ABTEC) for the screening & development of novel gutbiotics. All the probiotic strains used in this product are stable in nature.
The chairman of ABTEC Ltd., Mr. K.J. Jacob, said, “The coupling of EXPATICA’s innovation and ABTEC’s R&D base will certainly give an extra boost to our start-ups. This partnership aims to move from intent to implementation, turning this MoU into measurable outcomes and tangible results. I want to express my gratitude to the management and the dedicated teams at both organizations, who have worked tirelessly to bring this agreement to fruition.”
Dr. Sachindra Nath Mandal, Executive Director of EXPATICA BIOPHARMACEUTICA, said, “This partnership marks a pivotal moment in our shared journey to transform biopharmaceutical innovation. Our collaboration will accelerate R&D and drive scientific excellence. Together, we’re committed to making a meaningful impact on global health.”
Mr. Bibin Jacob, Managing Director and CEO of ABTEC Ltd. Said, “We are excited to partner with ABTEC Ltd., to drive innovation in Agri- Livestock and Start-up Entrepreneurship”.
Dr. Mithilesh Jaiswal (Additional Director R&D) said, “This collaboration aligns with our commitment to developing and delivering effective and eco-friendly solutions for the sustainable health benefits of Agri-Livestock.
